Corcept Therapeutics CORT Income taxes payable – long-term
Income taxes payable – long-term at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccruedIncomeTaxesNoncurrent.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's income taxes payable – long-term.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's income taxes payable – long-term?
- Corcept Therapeutics (CORT) reported income taxes payable – long-term of $15.33M in Q1 2026.
- How has Corcept Therapeutics's income taxes payable – long-term changed year-over-year?
- Corcept Therapeutics's income taxes payable – long-term increased by 7.6% year-over-year, from $14.25M to $15.33M.
- What is the long-term trend for Corcept Therapeutics's income taxes payable – long-term?
- Over 5 years (2020 to 2025), Corcept Therapeutics's income taxes payable – long-term has grown at a 107.1% compound annual growth rate (CAGR), from $398K to $15.18M.